REGENXBIO Inc. (RGNX)

REGENXBIO Revenue

In the year 2023, REGENXBIO had annual revenue of $90.24M, a decrease of -19.94%. Revenue in the quarter ending December 31, 2023 was $22.21M, a -29.13% decrease year-over-year.

• Revenue (ttm): $90.24M
• Revenue Growth: -19.94%
• P/S Ratio: 8.71
• Revenue / Employee: $262,331
• Employees: 344
• Market Cap: 766.25M USD

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2023	90.24M	-22.48M	-19.94%
Dec 31, 2022	112.72M	-357.62M	-76.03%
Dec 31, 2021	470.35M	315.78M	204.30%
Dec 31, 2020	154.57M	119.33M	338.70%
Dec 31, 2019	35.23M	-183.27M	-83.88%
Dec 31, 2018	218.51M	208.11M	2,002.42%
Dec 31, 2017	10.39M	5.80M	126.48%
Dec 31, 2016	4.59M	-3.00M	-39.52%
Dec 31, 2015	7.59M	1.47M	23.99%
Dec 31, 2014	6.12M	33.00K	0.54%
Dec 31, 2013	6.09M	-	-

Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.